@entity342 deprivation in @entity1 with XXXX is associated with an increased rate of bone loss.

@entity1 @entity79 @entity263 @entity342
The objective of this work was to determine the effect of @entity342 deprivation therapy (ADT) on rates of @entity79 ( @entity79 ) loss in @entity1 with @entity263 . It was a prospective study comparing @entity1 receiving ADT to age matched controls for 2 y. Subjects received a history, physical exam, @entity79 measurement, and laboratory evaluation every 6 months. Thirty-nine subjects receiving continuous ADT for @entity263 (subjects) were compared to 39 age-matched controls not receiving ADT (controls). Twenty-three subjects and 30 controls completed the study through 24 months. @entity1 in the ADT group demonstrated greater rates of @entity79 loss than @entity1 in the control group at every site except the lumbar spine. Twenty-four month per cent of @entity79 loss is presented as mean+/-standard error (s.e.). At the distal forearm, the ADT group value was -9.4%+/-1.0% and -4.4%+/-0.3% for controls (P<0.0005). The ADT group femoral neck values were -1.9%+/-0.7% and 0.6%+/-0.5% in the control group (P=0.0016). The ADT group total hip value was -1.5%+/-1.0% and 0.8%+/-0.5% in the control group (P=0.0018). The ADT group trochanter value was -2.0%+/-1.3% and -0.1%+/-0.5% in the control group (P=0.0019). The ADT group lumbar spine value was -0.2%+/-0.8 % and 1.1%+/-0.6% in the control group (P=0.079). Our data demonstrate greater rates of @entity79 loss in @entity1 receiving @entity342 deprivation therapy for @entity263 .
